Section Arrow
Quote
ARTV.NASDAQ
- Artiva Biotherapeutics Inc
Quotes are at least 15-min delayed:2025/06/02 04:49 EDT
Last
 1.93
-0.12 (-5.85%)
Day High 
2.04 
Prev. Close
2.05 
1-M High
2.56 
Volume 
65.52K 
Bid
1.78
Ask
2.09
Day Low
1.88 
Open
2.04 
1-M Low
1.8 
Market Cap 
49.94M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.02 
20-SMA 2.07 
50-SMA 2.51 
52-W High 17.31 
52-W Low 1.78 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.04/-3.44
Enterprise Value
60.56M
Balance Sheet
Book Value Per Share
6.93
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
251.00K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
INABIN8bio0.1446-0.0088-5.74%-- 
BLRXBioLineRx Ltd5.18+1.3891+36.64%-- 
IMNNImunon2.45+0.46+23.12%-- 
NCNANuCana plc0.03525-0.00175-4.73%-- 
MRNAModerna26.58-0.35-1.30%-- 
Quotes are at least 15-min delayed：2025/06/02 04:49 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program ofthe company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.